• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist

DVAX:US

1.5000 USD 0.00000.00%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Dynavax Technologies Corp (DVAX)

Open: 1.5000 Day's Range: 1.4600 - 1.5300 Volume: 1,116,203
Previous Close: 1.5000 52wk Range: 0.9800 - 2.6800 1-Yr Rtn: -37.24%

Stock Chart for DVAX

No chart data available.
  • DVAX:US 1.5000
  • 1D
  • 1M
  • 1Y
1.5000
Interactive DVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DVAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3651
Est. EPS (USD) (12/2014) -0.2860
Est. PEG Ratio -
Market Cap (M USD) 394.28
Shares Outstanding (M) 262.86
30 Day Average Volume 3,143,878
Price/Book (mrq) 2.1160
Price/Sale (ttm) 25.8578
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DVAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DVAX

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Eddie GrayChief Executive OfficerRobert Lee CoffmanVP/Chief Scientific Officer
Robert JanssenVP:Clinical Dev/Chief Medical Ofcr
More Company Profile & Key Executives for DVAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil